Original articles

• A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain

  Josep Comín-Colet, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, Cristina Enjuanes-Grau, Florian S. Gutzwiller, Stefan D. Anker, Piotr Ponikowski

  Rev Esp Cardiol. 2015;68:846-51

• Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2

  José M. de la Torre Hernández, Juan F. Oteo Domínguez, Felipe Hernández, Tamara García Camarero, Omar Abdul-Jawad Altisent, Fernando Rivero Crespo, José D. Cascón, Germán Zavala, Federico Gimeno, Antonio L. Arrebola Moreno, Leire Andraka, Antonio Gómez Menchero, Francisco Bosa, Xavier Carrillo, Ángel Sánchez Recalde, Fernando Alfonso, Armando Pérez de Prado, Ramón López Palop, Juan Sanchis, José A. Diarte de Miguel, Manuel Jiménez Navarro, Luz Muñoz, Antonio Ramírez Moreno, Helena Tizón Marcos, on behalf of the ESTROFA-DAPT and ESTROFA-2 study groups

  Rev Esp Cardiol. 2015;68:838-45

• Impact of Acute Coronary Syndrome Complicated by Ventricular Fibrillation on Long-term Incidence of Sudden Cardiac Death

  Belén Álvarez-Álvarez, Noelia Bouzas-Cruz, Emad Abu-Assi, Sergio Raposeiras-Roubin, Andrea López-López, María Cristina González Cambeiro, Carlos Peña-Gil, José María García-Acuña, José Ramón González-Juanatey

  Rev Esp Cardiol. 2015;68:878-84

• Assessment of Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Primary Health Care in Galicia, Spain: ANFAGAL Study

  Sergio Cinza-Sanjurjo, Daniel Rey-Aldana, Enrique Gestal-Pereira, Carlos Calvo-Gómez, on behalf of the investigators of the ANFAGAL (ANticoagulación en pacientes con Fibrilación Auricular en el ámbito de atención primaria de GALicia) study

  Rev Esp Cardiol. 2015;68:753-60

• Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors

  Manuel Anguita Sánchez, Vicente Bertomeu Martínez, Ángel Cequier Fillat, on behalf of the CALIFA study researchers

  Rev Esp Cardiol. 2015;68:761-8

• Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study

  Vivencio Barrios, Carlos Escobar, Luis Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García

  Rev Esp Cardiol. 2015;68:769-76

• Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry

  María G. Crespo-Leiro, Javier Segovia-Cubero, José González-Costello, Antoni Bayes-Genis, Silvia López-Fernández, Eulàlia Roig, Marisa Sanz-Julve, Carla Fernández-Vivancos, Manuel de Mora-Martín, José Manuel García-Pinilla, Alfonso Varela-Román, Luis Almenar-Bonet, Antonio Lara-Padrón, Luis de la Fuente-Galán, Juan Delgado-Jiménez, on behalf of the project research team

  Rev Esp Cardiol. 2015;68:785-93

• Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients

  Ernest Spitzer, Dik Heg, Giulio G. Stefanini, Stefan Stortecky, Anne W.S. Rutjes, Lorenz Räber, Stefan Blöchlinger, Thomas Pilgrim, Peter Jüni, Stephan Windecker

  Rev Esp Cardiol. 2015;68:746-52

• Long-term Prognosis of Patients With Non—ST-segment Elevation Acute Myocardial Infarction and Coronary Arteries Without Significant Stenosis

  Alfredo Redondo-Diéguez, Rocío Gonzalez-Ferreiro, Emad Abu-Assi, Sergio Raposeiras-Roubin, Ozoda Aidhodjayeva, Andrea López-López, María Castiñeira-Busto, Carlos Peña-Gil, Jose María García-Acuña, José Ramón González-Juanatey

  Rev Esp Cardiol. 2015;68:777-84

• Basic Study and Clinical Implications of Left Ventricular False Tendon. Is it Associated With Innocent Murmur in Children or Heart Disease?

  Francisco Sánchez Ferrer, María Luisa Sánchez Ferrer, María Dolores Grima Murcia, Marina Sánchez Ferrer, Francisco Sánchez del Campo

  Rev Esp Cardiol. 2015;68:700-5

• Long-term Effects of Plant Stanols on the Lipid Profile of Patients With Hypercholesterolemia. A Randomized Clinical Trial

  Ignacio Párraga-Martínez, Jesús D. López-Torres-Hidalgo, José M. del Campo-del Campo, María P. Galdón-Blesa, Juan C. Precioso-Yáñez, Joseba Rabanales-Sotos, Mercedes García-Reyes-Ramos, Fernando Andrés-Pretel, Beatriz Navarro-Bravo, Ángeles Lloret-Callejo

  Rev Esp Cardiol. 2015;68:665-71

• Leptin Reference Values and Cutoffs for Identifying Cardiometabolic Abnormalities in the Spanish Population

  Teresa Gijón-Conde, Auxiliadora Graciani, Pilar Guallar-Castillón, M. Teresa Aguilera, Fernando Rodríguez-Artalejo, José R. Banegas

  Rev Esp Cardiol. 2015;68:672-9

• Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters

  Jose Angel Urbano-Moral, Dakshin Gangadharamurthy, Raymond L. Comenzo, Natesa G. Pandian, Ayan R. Patel

  Rev Esp Cardiol. 2015;68:657-64

• Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain

  Gonzalo Barón Esquivias, Ginés Escolar Albaladejo, José Luis Zamorano, Lourdes Betegón Nicolás, Cristina Canal Fontcuberta, Marina de Salas-Cansado, Darío Rubio-Rodríguez, Carlos Rubio-Terrés

  Rev Esp Cardiol. 2015;68:680-90

• Prevalence of Stable Angina in Spain. Results of the OFRECE Study

  Joaquín J. Alonso, Javier Muñiz, Juan José Gómez-Doblas, Gustavo Rodríguez-Roca, José María Lobos, Gaietà Permanyer-Miralda, Manuel Anguita, Francisco Javier Chorro, Eulàlia Roig, on behalf of the OFRECE study researchers

  Rev Esp Cardiol. 2015;68:691-9

• Safety of Outpatient Implantation of the Implantable Cardioverter-defibrillator

  Tomás Datino, Ángel Miracle Blanco, Alberto Núñez García, Esteban González-Torrecilla, Felipe Atienza Fernández, Ángel Arenal Maíz, Jesús Hernández-Hernández, Pablo Ávila Alonso, Gabriel Eidelman, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2015;68:579-84

• Prevalence of Atherogenic Dyslipidemia in Spanish Hypertensive Patients and Its Relationship With Blood Pressure Control and Silent Organ Damage

  Alejandro de la Sierra, Manuel Gorostidi, Pedro Aranda, Emili Corbella, Xavier Pintó

  Rev Esp Cardiol. 2015;68:592-8

• Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated With Allograft Vasculopathy: Intracoronary Measurement Validation

  Jesús G. Mirelis, Pablo García-Pavía, Miguel A. Cavero, Esther González-López, Mauro Echavarria-Pinto, Miguel Pastrana, Javier Segovia, Juan F. Oteo, Luis Alonso-Pulpón, Javier Escaned

  Rev Esp Cardiol. 2015;68:571-8

• Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension

  Zhao Qingyan, Jiang Xuejun, Tang Yanhong, Dai Zixuan, Wang Xiaozhan, Wang Xule, Guo Zongwen, Hu Wei, Yu Shengbo, Huang Congxin

  Rev Esp Cardiol. 2015;68:562-70

• Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?

  Sergio Raposeiras-Roubín, Emad Abu-Assi, Alfredo Redondo-Diéguez, Rocío González-Ferreiro, Andrea López-López, Noelia Bouzas-Cruz, María Castiñeira-Busto, Carlos Peña Gil, José María García-Acuña, José Ramón González-Juanatey

  Rev Esp Cardiol. 2015;68:585-91